Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1420438

Cover Image

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1420438

Circadian Rhythm Sleep Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region:

PUBLISHED:
PAGES: 310 Pages
DELIVERY TIME: 2-5 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PPT Slides/PDF & Excel (Enterprise License)
USD 4995

Add to Cart

Description

Table of Contents

The global Circadian Rhythm Sleep Treatment Market is poised for significant growth from 2024 to 2031. Starting at US$ 740 million in 2024, the market is projected to expand to US$ 990 million by 2031.

Growth Factors:

The global Circadian Rhythm Sleep Treatment Market is witnessing significant growth due to the rising prevalence of sleep disorders, including Delayed Sleep Phase Syndrome, Advanced Sleep Phase Syndrome, Non-24-h sleep-wake syndrome. This increased need for proper sleep treatment is driving market expansion. Additionally, the market is propelled by product advancements in therapy devices and the adoption of drugs for circadian rhythm sleep treatment.

Furthermore, a disrupted sleep pattern poses an increased risk of fatal accidents, with estimates suggesting a potential doubling of global deaths in car accidents and a notable portion attributed to exhaustion or drowsiness. Similarly, workplace accidents are projected to rise due to disrupted sleep. This elevated risk of fatal accidents contributes to an increased demand for circadian rhythm sleep treatment, further propelling market growth.

Restraints

Limited awareness about the critical issues related to circadian rhythm sleep disorders in underdeveloped nations could hinder the expansion of the circadian rhythm sleep treatment market. Additionally, negligence towards potential drug side effects and insufficient attention to sleep problems may impede the market's growth.

Competitive Analysis

The Circadian Rhythm Sleep Treatment industry is characterized by intense competition and significant consolidation, primarily driven by major players. Mergers and acquisitions are prominent strategies as the industry experiences growth. Key market players are strategically opting for these initiatives to expand their product portfolios and increase market share.

One notable player, Natus Medical Incorporated in the USA, has introduced the Embla N7000 system designed for overnight PSG (Polysomnography) between 10 p.m. and 6 a.m. The system is supervised by experienced sleep physicians following the guidelines outlined in the AASM manual 2.5.

In addition to inorganic expansion through mergers and acquisitions, companies are also exploring organic growth strategies. Continuous innovation remains vital for the circadian rhythm sleep treatment market, and this trend is expected to persist throughout the forecast period (2024-2031).

Key players in the Circadian Rhythm Sleep Treatment Market including-

  • Natus Medical Incorporated
  • Compumedics Ltd. -
  • Teva Pharmaceutical Industries Ltd
  • Takeda Pharmaceutical Company
  • Koninklijke Philips N.V
  • Mylan N.V
  • Fitbit, Inc
  • Garmin Ltd
  • Lucimed S.A.
  • RedMed Inc.
  • Compass Health Brands (Carex Health)
  • Beurer GmbH
  • Samarit Medical AG
  • Lanaform N.V.

Circadian Rhythm Sleep Treatment Market Categorization

Circadian Rhythm Sleep Treatment Market by Disorder

  • Delayed Sleep Phase Syndrome
  • Advanced Sleep Phase Syndrome
  • Non-24-h sleep-wake syndrome
  • Irregular Sleep-Wake Disorder
  • Shift Work Disorder
  • Jet Lag

Circadian Rhythm Sleep Treatment Market by Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa (MEA)
Show more

Table of Contents

1. Executive Summary

  • 1.1. Global Circadian Rhythm Sleep Treatment Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value and Volume, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Production Output and Trade Statistics, 2018 - 2023

  • 3.1. Global Circadian Rhythm Sleep Treatment Production Output, by Region, Value (US$ Mn) and Volume (Million Units), 2018 - 2023
    • 3.1.1. North America
    • 3.1.2. Europe
    • 3.1.3. Asia Pacific
    • 3.1.4. Latin America
    • 3.1.5. Middle East and Africa

4. Price Analysis, 2018 - 2023

  • 4.1. Global Average Price Analysis, by Treatment Type, US$ Per Unit, 2018 - 2023
  • 4.2. Prominent Factor Affecting Circadian Rhythm Sleep Treatment Prices
  • 4.3. Global Average Price Analysis, by Region, US$ Per Unit

5. Global Circadian Rhythm Sleep Treatment Market Outlook, 2018 - 2031

  • 5.1. Global Circadian Rhythm Sleep Treatment Market Outlook, by Treatment Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Device
        • 5.1.1.1.1. Therapeutic Devices
          • 5.1.1.1.1.1. Light Box
          • 5.1.1.1.1.2. Desk Lamps
          • 5.1.1.1.1.3. Light Visor
          • 5.1.1.1.1.4. Dawn Simulator
        • 5.1.1.1.2. Diagnostic Devices
          • 5.1.1.1.2.1. Actigraphy Sensors
            • 5.1.1.1.2.1.1. Wrist and Hand band Actigraphy Devices
            • 5.1.1.1.2.1.2. Wearable Actigraphy Devices
          • 5.1.1.1.2.2. Polysomnography Devices
            • 5.1.1.1.2.2.1. Fixed Polysomnography Devices
            • 5.1.1.1.2.2.2. Portable Polysomnography Devices
      • 5.1.1.2. Drugs
        • 5.1.1.2.1. Benzodiazepines
        • 5.1.1.2.2. Nonbenzodiazepine hypnotics
        • 5.1.1.2.3. Orexin receptor antagonists
        • 5.1.1.2.4. Melatonin receptor agonist
      • 5.1.1.3. Chronotherapy
  • 5.2. Global Circadian Rhythm Sleep Treatment Market Outlook, by Disorder, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Delayed Sleep Phase Syndrome (DSPS)
      • 5.2.1.2. Advanced Sleep Phase Syndrome (ASPS)
      • 5.2.1.3. Non-24-h Sleep-Wake Syndrome
      • 5.2.1.4. Irregular Sleep-Wake Disorder (ISWD)
      • 5.2.1.5. Shift Work Disorder
      • 5.2.1.6. Jet Lag
  • 5.3. Global Circadian Rhythm Sleep Treatment Market Outlook, by Distribution Channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Institutional Sales
        • 5.3.1.1.1. Home Care Settings
        • 5.3.1.1.2. Wellness Centers & Spa
        • 5.3.1.1.3. Sleep Testing Centers
        • 5.3.1.1.4. Specialty Clinics
        • 5.3.1.1.5. Hospitals
      • 5.3.1.2. Retail Sales
        • 5.3.1.2.1. Retail Pharmacies
        • 5.3.1.2.2. Drug Stores
        • 5.3.1.2.3. Online Sales
  • 5.4. Global Circadian Rhythm Sleep Treatment Market Outlook, by Region, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. North America
      • 5.4.1.2. Europe
      • 5.4.1.3. Asia Pacific
      • 5.4.1.4. Latin America
      • 5.4.1.5. Middle East & Africa

6. North America Circadian Rhythm Sleep Treatment Market Outlook, 2018 - 2031

  • 6.1. North America Circadian Rhythm Sleep Treatment Market Outlook, by Treatment Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Device
        • 6.1.1.1.1. Therapeutic Devices
          • 6.1.1.1.1.1. Light Box
          • 6.1.1.1.1.2. Desk Lamps
          • 6.1.1.1.1.3. Light Visor
          • 6.1.1.1.1.4. Dawn Simulator
        • 6.1.1.1.2. Diagnostic Devices
          • 6.1.1.1.2.1. Actigraphy Sensors
            • 6.1.1.1.2.1.1. Wrist and Hand band Actigraphy Devices
            • 6.1.1.1.2.1.2. Wearable Actigraphy Devices
          • 6.1.1.1.2.2. Polysomnography Devices
            • 6.1.1.1.2.2.1. Fixed Polysomnography Devices
            • 6.1.1.1.2.2.2. Portable Polysomnography Devices
      • 6.1.1.2. Drugs
        • 6.1.1.2.1. Benzodiazepines
        • 6.1.1.2.2. Nonbenzodiazepine hypnotics
        • 6.1.1.2.3. Orexin receptor antagonists
        • 6.1.1.2.4. Melatonin receptor agonist
      • 6.1.1.3. Chronotherapy
  • 6.2. North America Circadian Rhythm Sleep Treatment Market Outlook, by Disorder, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Delayed Sleep Phase Syndrome (DSPS)
      • 6.2.1.2. Advanced Sleep Phase Syndrome (ASPS)
      • 6.2.1.3. Non-24-h Sleep-Wake Syndrome
      • 6.2.1.4. Irregular Sleep-Wake Disorder (ISWD)
      • 6.2.1.5. Shift Work Disorder
      • 6.2.1.6. Jet Lag
  • 6.3. North America Circadian Rhythm Sleep Treatment Market Outlook, by Distribution Channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. Institutional Sales
        • 6.3.1.1.1. Home Care Settings
        • 6.3.1.1.2. Wellness Centers & Spa
        • 6.3.1.1.3. Sleep Testing Centers
        • 6.3.1.1.4. Specialty Clinics
        • 6.3.1.1.5. Hospitals
      • 6.3.1.2. Retail Sales
        • 6.3.1.2.1. Retail Pharmacies
        • 6.3.1.2.2. Drug Stores
        • 6.3.1.2.3. Online Sales
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis
  • 6.4. North America Circadian Rhythm Sleep Treatment Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. U.S. Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 6.4.1.2. U.S. Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 6.4.1.3. U.S. Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 6.4.1.4. Canada Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 6.4.1.5. Canada Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 6.4.1.6. Canada Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Europe Circadian Rhythm Sleep Treatment Market Outlook, 2018 - 2031

  • 7.1. Europe Circadian Rhythm Sleep Treatment Market Outlook, by Treatment Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Device
        • 7.1.1.1.1. Therapeutic Devices
          • 7.1.1.1.1.1. Light Box
          • 7.1.1.1.1.2. Desk Lamps
          • 7.1.1.1.1.3. Light Visor
          • 7.1.1.1.1.4. Dawn Simulator
        • 7.1.1.1.2. Diagnostic Devices
          • 7.1.1.1.2.1. Actigraphy Sensors
            • 7.1.1.1.2.1.1. Wrist and Hand band Actigraphy Devices
            • 7.1.1.1.2.1.2. Wearable Actigraphy Devices
          • 7.1.1.1.2.2. Polysomnography Devices
            • 7.1.1.1.2.2.1. Fixed Polysomnography Devices
            • 7.1.1.1.2.2.2. Portable Polysomnography Devices
      • 7.1.1.2. Drugs
        • 7.1.1.2.1. Benzodiazepines
        • 7.1.1.2.2. Nonbenzodiazepine hypnotics
        • 7.1.1.2.3. Orexin receptor antagonists
        • 7.1.1.2.4. Melatonin receptor agonist
      • 7.1.1.3. Chronotherapy
  • 7.2. Europe Circadian Rhythm Sleep Treatment Market Outlook, by Disorder, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.2.1. Key Highlights
      • 7.2.1.1. Delayed Sleep Phase Syndrome (DSPS)
      • 7.2.1.2. Advanced Sleep Phase Syndrome (ASPS)
      • 7.2.1.3. Non-24-h Sleep-Wake Syndrome
      • 7.2.1.4. Irregular Sleep-Wake Disorder (ISWD)
      • 7.2.1.5. Shift Work Disorder
      • 7.2.1.6. Jet Lag
  • 7.3. Europe Circadian Rhythm Sleep Treatment Market Outlook, by Distribution Channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Institutional Sales
        • 7.3.1.1.1. Home Care Settings
        • 7.3.1.1.2. Wellness Centers & Spa
        • 7.3.1.1.3. Sleep Testing Centers
        • 7.3.1.1.4. Specialty Clinics
        • 7.3.1.1.5. Hospitals
      • 7.3.1.2. Retail Sales
        • 7.3.1.2.1. Retail Pharmacies
        • 7.3.1.2.2. Drug Stores
        • 7.3.1.2.3. Online Sales
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis
  • 7.4. Europe Circadian Rhythm Sleep Treatment Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. Germany Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.2. Germany Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.3. Germany Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.4. U.K. Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.5. U.K. Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.6. U.K. Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.7. France Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.8. France Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.9. France Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.10. Italy Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.11. Italy Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.12. Italy Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.13. Turkey Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.14. Turkey Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.15. Turkey Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.16. Russia Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.17. Russia Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.18. Russia Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.19. Rest of Europe Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.20. Rest of Europe Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.21. Rest of Europe Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Asia Pacific Circadian Rhythm Sleep Treatment Market Outlook, 2018 - 2031

  • 8.1. Asia Pacific Circadian Rhythm Sleep Treatment Market Outlook, by Treatment Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Device
        • 8.1.1.1.1. Therapeutic Devices
          • 8.1.1.1.1.1. Light Box
          • 8.1.1.1.1.2. Desk Lamps
          • 8.1.1.1.1.3. Light Visor
          • 8.1.1.1.1.4. Dawn Simulator
        • 8.1.1.1.2. Diagnostic Devices
          • 8.1.1.1.2.1. Actigraphy Sensors
            • 8.1.1.1.2.1.1. Wrist and Hand band Actigraphy Devices
            • 8.1.1.1.2.1.2. Wearable Actigraphy Devices
          • 8.1.1.1.2.2. Polysomnography Devices
            • 8.1.1.1.2.2.1. Fixed Polysomnography Devices
            • 8.1.1.1.2.2.2. Portable Polysomnography Devices
      • 8.1.1.2. Drugs
        • 8.1.1.2.1. Benzodiazepines
        • 8.1.1.2.2. Nonbenzodiazepine hypnotics
        • 8.1.1.2.3. Orexin receptor antagonists
        • 8.1.1.2.4. Melatonin receptor agonist
      • 8.1.1.3. Chronotherapy
  • 8.2. Asia Pacific Circadian Rhythm Sleep Treatment Market Outlook, by Disorder, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Delayed Sleep Phase Syndrome (DSPS)
      • 8.2.1.2. Advanced Sleep Phase Syndrome (ASPS)
      • 8.2.1.3. Non-24-h Sleep-Wake Syndrome
      • 8.2.1.4. Irregular Sleep-Wake Disorder (ISWD)
      • 8.2.1.5. Shift Work Disorder
      • 8.2.1.6. Jet Lag
  • 8.3. Asia Pacific Circadian Rhythm Sleep Treatment Market Outlook, by Distribution Channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. Institutional Sales
        • 8.3.1.1.1. Home Care Settings
        • 8.3.1.1.2. Wellness Centers & Spa
        • 8.3.1.1.3. Sleep Testing Centers
        • 8.3.1.1.4. Specialty Clinics
        • 8.3.1.1.5. Hospitals
      • 8.3.1.2. Retail Sales
        • 8.3.1.2.1. Retail Pharmacies
        • 8.3.1.2.2. Drug Stores
        • 8.3.1.2.3. Online Sales
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis
  • 8.4. Asia Pacific Circadian Rhythm Sleep Treatment Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.4.1. Key Highlights
      • 8.4.1.1. China Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.2. China Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.3. China Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.4. Japan Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.5. Japan Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.6. Japan Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.7. South Korea Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.8. South Korea Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.9. South Korea Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.10. India Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.11. India Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.12. India Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.13. Southeast Asia Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.14. Southeast Asia Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.15. Southeast Asia Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.16. Rest of Asia Pacific Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.17. Rest of Asia Pacific Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.18. Rest of Asia Pacific Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Latin America Circadian Rhythm Sleep Treatment Market Outlook, 2018 - 2031

  • 9.1. Latin America Circadian Rhythm Sleep Treatment Market Outlook, by Treatment Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 9.1.1. Key Highlights
      • 9.1.1.1. Device
        • 9.1.1.1.1. Therapeutic Devices
          • 9.1.1.1.1.1. Light Box
          • 9.1.1.1.1.2. Desk Lamps
          • 9.1.1.1.1.3. Light Visor
          • 9.1.1.1.1.4. Dawn Simulator
        • 9.1.1.1.2. Diagnostic Devices
          • 9.1.1.1.2.1. Actigraphy Sensors
            • 9.1.1.1.2.1.1. Wrist and Hand band Actigraphy Devices
            • 9.1.1.1.2.1.2. Wearable Actigraphy Devices
          • 9.1.1.1.2.2. Polysomnography Devices
            • 9.1.1.1.2.2.1. Fixed Polysomnography Devices
            • 9.1.1.1.2.2.2. Portable Polysomnography Devices
      • 9.1.1.2. Drugs
        • 9.1.1.2.1. Benzodiazepines
        • 9.1.1.2.2. Nonbenzodiazepine hypnotics
        • 9.1.1.2.3. Orexin receptor antagonists
        • 9.1.1.2.4. Melatonin receptor agonist
      • 9.1.1.3. Chronotherapy
  • 9.2. Latin America Circadian Rhythm Sleep Treatment Market Outlook, by Disorder, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 9.2.1. Key Highlights
      • 9.2.1.1. Delayed Sleep Phase Syndrome (DSPS)
      • 9.2.1.2. Advanced Sleep Phase Syndrome (ASPS)
      • 9.2.1.3. Non-24-h Sleep-Wake Syndrome
      • 9.2.1.4. Irregular Sleep-Wake Disorder (ISWD)
      • 9.2.1.5. Shift Work Disorder
      • 9.2.1.6. Jet Lag
  • 9.3. Latin America Circadian Rhythm Sleep Treatment Market Outlook, by Distribution Channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 9.3.1. Key Highlights
      • 9.3.1.1. Institutional Sales
        • 9.3.1.1.1. Home Care Settings
        • 9.3.1.1.2. Wellness Centers & Spa
        • 9.3.1.1.3. Sleep Testing Centers
        • 9.3.1.1.4. Specialty Clinics
        • 9.3.1.1.5. Hospitals
      • 9.3.1.2. Retail Sales
        • 9.3.1.2.1. Retail Pharmacies
        • 9.3.1.2.2. Drug Stores
        • 9.3.1.2.3. Online Sales
    • 9.3.2. BPS Analysis/Market Attractiveness Analysis
  • 9.4. Latin America Circadian Rhythm Sleep Treatment Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 9.4.1. Key Highlights
      • 9.4.1.1. Brazil Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.4.1.2. Brazil Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.4.1.3. Brazil Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.4.1.4. Mexico Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.4.1.5. Mexico Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.4.1.6. Mexico Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.4.1.7. Argentina Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.4.1.8. Argentina Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.4.1.9. Argentina Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.4.1.10. Rest of Latin America Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.4.1.11. Rest of Latin America Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.4.1.12. Rest of Latin America Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 9.4.2. BPS Analysis/Market Attractiveness Analysis

10. Middle East & Africa Circadian Rhythm Sleep Treatment Market Outlook, 2018 - 2031

  • 10.1. Middle East & Africa Circadian Rhythm Sleep Treatment Market Outlook, by Treatment Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.1.1. Key Highlights
      • 10.1.1.1. Device
        • 10.1.1.1.1. Therapeutic Devices
          • 10.1.1.1.1.1. Light Box
          • 10.1.1.1.1.2. Desk Lamps
          • 10.1.1.1.1.3. Light Visor
          • 10.1.1.1.1.4. Dawn Simulator
        • 10.1.1.1.2. Diagnostic Devices
          • 10.1.1.1.2.1. Actigraphy Sensors
            • 10.1.1.1.2.1.1. Wrist and Hand band Actigraphy Devices
            • 10.1.1.1.2.1.2. Wearable Actigraphy Devices
          • 10.1.1.1.2.2. Polysomnography Devices
            • 10.1.1.1.2.2.1. Fixed Polysomnography Devices
            • 10.1.1.1.2.2.2. Portable Polysomnography Devices
      • 10.1.1.2. Drugs
        • 10.1.1.2.1. Benzodiazepines
        • 10.1.1.2.2. Nonbenzodiazepine hypnotics
        • 10.1.1.2.3. Orexin receptor antagonists
        • 10.1.1.2.4. Melatonin receptor agonist
      • 10.1.1.3. Chronotherapy
  • 10.2. Middle East & Africa Circadian Rhythm Sleep Treatment Market Outlook, by Disorder, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.2.1. Key Highlights
      • 10.2.1.1. Delayed Sleep Phase Syndrome (DSPS)
      • 10.2.1.2. Advanced Sleep Phase Syndrome (ASPS)
      • 10.2.1.3. Non-24-h Sleep-Wake Syndrome
      • 10.2.1.4. Irregular Sleep-Wake Disorder (ISWD)
      • 10.2.1.5. Shift Work Disorder
      • 10.2.1.6. Jet Lag
  • 10.3. Middle East & Africa Circadian Rhythm Sleep Treatment Market Outlook, by Distribution Channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.3.1. Key Highlights
      • 10.3.1.1. Institutional Sales
        • 10.3.1.1.1. Home Care Settings
        • 10.3.1.1.2. Wellness Centers & Spa
        • 10.3.1.1.3. Sleep Testing Centers
        • 10.3.1.1.4. Specialty Clinics
        • 10.3.1.1.5. Hospitals
      • 10.3.1.2. Retail Sales
        • 10.3.1.2.1. Retail Pharmacies
        • 10.3.1.2.2. Drug Stores
        • 10.3.1.2.3. Online Sales
    • 10.3.2. BPS Analysis/Market Attractiveness Analysis
  • 10.4. Middle East & Africa Circadian Rhythm Sleep Treatment Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.4.1. Key Highlights
      • 10.4.1.1. GCC Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.2. GCC Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.3. GCC Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.4. South Africa Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.5. South Africa Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.6. South Africa Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.7. Egypt Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.8. Egypt Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.9. Egypt Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.10. Nigeria Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.11. Nigeria Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.12. Nigeria Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.13. Rest of Middle East & Africa Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.14. Rest of Middle East & Africa Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.15. Rest of Middle East & Africa Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.4.2. BPS Analysis/Market Attractiveness Analysis

11. Competitive Landscape

  • 11.1. By Treatment Type vs by Disorder Heatmap
  • 11.2. Company Market Share Analysis, 2023
  • 11.3. Competitive Dashboard
  • 11.4. Company Profiles
    • 11.4.1. Natus Medical Incorporated
      • 11.4.1.1. Company Overview
      • 11.4.1.2. Product Portfolio
      • 11.4.1.3. Financial Overview
      • 11.4.1.4. Business Strategies and Development
    • 11.4.2. Compumedics Ltd.
      • 11.4.2.1. Company Overview
      • 11.4.2.2. Product Portfolio
      • 11.4.2.3. Financial Overview
      • 11.4.2.4. Business Strategies and Development
    • 11.4.3. Teva Pharmaceutical Industries Ltd.
      • 11.4.3.1. Company Overview
      • 11.4.3.2. Product Portfolio
      • 11.4.3.3. Financial Overview
      • 11.4.3.4. Business Strategies and Development
    • 11.4.4. Takeda Pharmaceutical Company
      • 11.4.4.1. Company Overview
      • 11.4.4.2. Product Portfolio
      • 11.4.4.3. Financial Overview
      • 11.4.4.4. Business Strategies and Development
    • 11.4.5. Koninklijke Philips N.V
      • 11.4.5.1. Company Overview
      • 11.4.5.2. Product Portfolio
      • 11.4.5.3. Financial Overview
      • 11.4.5.4. Business Strategies and Development
    • 11.4.6. Mylan N.V.
      • 11.4.6.1. Company Overview
      • 11.4.6.2. Product Portfolio
      • 11.4.6.3. Financial Overview
      • 11.4.6.4. Business Strategies and Development
    • 11.4.7. Fitbit, Inc
      • 11.4.7.1. Company Overview
      • 11.4.7.2. Product Portfolio
      • 11.4.7.3. Financial Overview
      • 11.4.7.4. Business Strategies and Development
    • 11.4.8. Garmin Ltd
      • 11.4.8.1. Company Overview
      • 11.4.8.2. Product Portfolio
      • 11.4.8.3. Financial Overview
      • 11.4.8.4. Business Strategies and Development
    • 11.4.9. Lucimed S.A.
      • 11.4.9.1. Company Overview
      • 11.4.9.2. Product Portfolio
      • 11.4.9.3. Financial Overview
      • 11.4.9.4. Business Strategies and Development
    • 11.4.10. RedMed Inc.
      • 11.4.10.1. Company Overview
      • 11.4.10.2. Product Portfolio
      • 11.4.10.3. Financial Overview
      • 11.4.10.4. Business Strategies and Development
    • 11.4.11. Compass Health Brands (Carex Health)
      • 11.4.11.1. Company Overview
      • 11.4.11.2. Product Portfolio
      • 11.4.11.3. Financial Overview
      • 11.4.11.4. Business Strategies and Development
    • 11.4.12. Beurer GmbH.
      • 11.4.12.1. Company Overview
      • 11.4.12.2. Product Portfolio
      • 11.4.12.3. Financial Overview
      • 11.4.12.4. Business Strategies and Development

12. Appendix

  • 12.1. Research Methodology
  • 12.2. Report Assumptions
  • 12.3. Acronyms and Abbreviations
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!